John Golubieski - Jan 27, 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Chief Financial Officer and Treasurer
Signature
John Golubieski
Stock symbol
BDSI
Transactions as of
Jan 27, 2022
Transactions value $
$1,367,131
Form type
4
Date filed
1/31/2022, 04:59 PM
Previous filing
Nov 5, 2021
Next filing
Mar 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Stock Options (right to buy) Award $1.37M +374K $3.66 374K Jan 27, 2022 Common Stock 374K $3.66 Direct F1, F2
transaction BDSI Restricted Stock Units Award $0 +66.9K $0.00 66.9K Jan 27, 2022 Common Stock 66.9K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
F2 The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
F3 The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
F4 Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.

Remarks:

Chief Financial Officer and Treasurer